Saving Lives With Hemostatic Medicine

Saving Lives With Hemostatic Medicine.


A cure-all commonly hand-me-down to prevent excess bleeding in surgeries could keep thousands of people from bleeding to death after trauma, a renewed study suggests. The drug, tranexamic acid (TXA) is cheap, by many available around the world and easily administered. It works by significantly reducing the rate at which blood clots fragment down, the researchers explained extra resources. "When people have serious injuries, whether from accidents or violence, and when they have bitter hemorrhage they can bleed to death.



This treatment reduces the chances of bleeding to death by about a sixth," said researcher Dr Ian Roberts, a professor of epidemiology at the London School of Hygiene and Tropical Medicine in the UK. According to Roberts, each year about 600000 tribe bleed to end worldwide as an example. "So, if you could diet that by a sixth, you've saved 100000 lives in one year".



The report, which was generally funded by philanthropic groups and the British government, is published in the June 15 online version of The Lancet. For the study, Roberts and colleagues in the CRASH-2 consortium randomly assigned more than 20000 trauma patients from 274 hospitals across 40 countries to injections of either TXA or placebo.



Among patients receiving TXA, the compute of extinction from any cause was cut by 10 percent compared to patients receiving placebo, the researchers found. In the TXA group, 14,5 percent of the patients died compared with 16 percent of the patients in the placebo group.



When the researchers looked at deaths from bleeding, those in the TXA circle sage a 15 percent reduction in mortality. Among patients receiving TXA, 4,9 percent died from bleeding, compared with 5,7 percent of the patients receiving placebo, they found. Although there was some torment that TXA might dispose to more callousness attacks, strokes or clots in the lungs, the researchers observed no such better among patients getting the drug.



Dr Jerrold H Levy, delegate chair for research at Emory University School of Medicine in Atlanta and maker of an accompanying journal editorial "these data are really neat, because any analysis to reduce mortality in trauma is, I think, a major finding". Using this psychedelic to treat trauma patients is a completely new idea. "I think people should over it TXA following trauma on the basis of this study".



Currently, TXA is not generally used in emergency rooms to touch on trauma patients, but Roberts believes that this study could change that. "It's not our job to demand doctors how to treat their patients, but this is a drug that is safe and effective in a condition where people have a high peril of death". The researchers believe that TXA could have even wider uses, such as reducing brain bleeds after knowledge injury. The drug could also be used to reduce postpartum bleeding, which the researchers predict causes some 100000 deaths a year worldwide.



In fact, a trial to see whether TXA can abbreviate postpartum bleeding has started, the team noted. Levy however, cautioned that the results of this scrutinize apply only to TXA and do not mean that people should try similar drugs hoping for similar results. "Everybody wants to be creative, but you have to appearance at the data, and they used TXA click this link. You can't get ingenious and say 'Ah, one of the other drugs will do the same thing' - you don't know that, and that's one of my concerns".

tag : patients bleeding percent researchers trauma people roberts receiving study

Post a comment

Private comment

Profile

ivankuleshov

Author:ivankuleshov
Welcome to FC2!

Latest journals
Latest comments
Latest trackbacks
Monthly archive
Category
Search form
Display RSS link.
Link
Friend request form

Want to be friends with this user.